By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -A boardroom shake-up at Novo Nordisk has handed ...

Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...

The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...

Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation over board composition. Key board members, including Chair Helge Lund, will ...

Further to company announcement no. 28 issued today, an Extraordinary General Meeting of Novo Nordisk A/S is called to elect ...

Wegovy's list price is $1,349. Novo Nordisk previously announced the discount prescription drug website GoodRx would sell prescribed Ozempic and Wegovy for $499 per month. Consumers also can purchase ...

Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...

Novo Nordisk, the Danish pharmaceutical firm that makes the weight-loss drugs, announced Friday that Ozempic and Wegovy are available at Costco pharmacies across the U.S. A one-month supply of the ...

Novo Nordisk NVO saw 18% sales growth and 40% operating profit growth at constant currencies in the second quarter, but management reduced 2025 guidance to 8%-14% sales growth and 10%-16% operating ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...